TransMedics Group

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade TransMedics Group 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TMDX

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. 

CEO
Waleed H. Hassanein
CEOWaleed H. Hassanein
Employees
898
Employees898
Headquarters
Andover, Massachusetts
HeadquartersAndover, Massachusetts
Founded
1998
Founded1998
Employees
898
Employees898

TMDX Key Statistics

Market cap
3.20B
Market cap3.20B
Price-Earnings ratio
25.06
Price-Earnings ratio25.06
Dividend yield
—
Dividend yield—
Average volume
1.60M
Average volume1.60M
High today
$92.99
High today$92.99
Low today
$89.50
Low today$89.50
Open price
$90.60
Open price$90.60
Volume
564.12K
Volume564.12K
52 Week high
$156.00
52 Week high$156.00
52 Week low
$60.11
52 Week low$60.11

Stock Snapshot

As of today, TransMedics Group(TMDX) shares are valued at $91.86. The company's market cap stands at 3.2B, with a P/E ratio of 25.06.

On 2026-11-16, TransMedics Group(TMDX) stock moved within a range of $89.50 to $92.99. With shares now at $91.86, the stock is trading +2.6% above its intraday low and -1.2% below the session's peak.

Trading volume for TransMedics Group(TMDX) stock has reached 564.12K, versus its average volume of 1.6M.

The stock's 52-week range extends from a low of $60.11 to a high of $156.00.

The stock's 52-week range extends from a low of $60.11 to a high of $156.00.

TMDX News

Simply Wall St 18h
TransMedics Group Could Be 11% Undervalued As It Raises 2026 Outlook

Why TransMedics Group Raised Its 2026 Outlook TransMedics Group (TMDX) lifted its 2026 revenue outlook after reporting third quarter and year to date results,...

TransMedics Group Could Be 11% Undervalued As It Raises 2026 Outlook
Simply Wall St 5d
TransMedics Group Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Unsurprisingly, TransMedics Group, Inc.'s ( ) stock price was strong on the back of its healthy earnings report. We did some analysis and think that investors a...

TransMedics Group Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Analyst ratings

69%

of 13 ratings
Buy
69.2%
Hold
30.8%
Sell
0%

People also own

Based on the portfolios of people who own TMDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.